Literature DB >> 2265605

Delineation of antigen contact residues on an MHC class II molecule.

J Peccoud1, P Dellabona, P Allen, C Benoist, D Mathis.   

Abstract

This report describes a detailed mutational analysis of a major histocompatibility complex class II molecule--the alpha chain of the Ak complex. Each residue from 50-79 was replaced by an alanine, and the effects on recognition of Ak by panels of antibodies and T cells determined. The results provide the strongest existing experimental evidence that the antigen binding site on a class II molecule can be modelled on the crystal structure of a class I molecule. The data have also permitted the delineation of residues that actually contact antigenic peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265605      PMCID: PMC552203          DOI: 10.1002/j.1460-2075.1990.tb07869.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

Review 1.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

Review 2.  Three-dimensional structure of antibodies.

Authors:  P M Alzari; M B Lascombe; R J Poljak
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

3.  Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor.

Authors:  P Ajitkumar; S S Geier; K V Kesari; F Borriello; M Nakagawa; J A Bluestone; M A Saper; D C Wiley; S G Nathenson
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

4.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

5.  Slot-machine mutagenesis of a polymorphic residue on the A kappa alpha-chain.

Authors:  D Landais; S Marchetto; C Waltzinger; M Pierres; C Benoist; D Mathis
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

6.  Peptide-mediated modulation of T-cell allorecognition.

Authors:  D D Eckels; J Gorski; J Rothbard; J R Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  T cell recognition of bovine ribonuclease. Self/non-self discrimination at the level of binding to the I-Ak molecule.

Authors:  R G Lorenz; A N Tyler; P M Allen
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

8.  Compartmentalization of MHC class II gene expression in transgenic mice.

Authors:  W van Ewijk; Y Ron; J Monaco; J Kappler; P Marrack; M Le Meur; P Gerlinger; B Durand; C Benoist; D Mathis
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

9.  Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.

Authors:  J M Buerstedde; L R Pease; A E Nilson; M P Bell; C Chase; G Buerstedde; D J McKean
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

10.  Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity.

Authors:  J M Vogel; A C Davis; D M McKinney; M McMillan; W J Martin; R S Goodenow
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  10 in total

1.  Genome-based expression profiling study of Hunner's ulcer type interstitial cystitis: an array of 40-gene model.

Authors:  Ling-Hong Tseng; Ilene Chen; Chao-Nin Wang; Yi-Hao Lin; L Keith Lloyd; Chyi-Long Lee
Journal:  Int Urogynecol J       Date:  2010-03-04       Impact factor: 2.894

Review 2.  Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system.

Authors:  K D Smith; Z B Kurago; C T Lutz
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.

Authors:  R Busch; I Cloutier; R P Sékaly; G J Hämmerling
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

4.  Exonic polymorphism vs intronic simple repeat hypervariability in MHC-DRB genes.

Authors:  H Ammer; F W Schwaiger; C Kammerbauer; M Gomolka; A Arriens; S Lazary; J T Epplen
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 6.  Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Paul M Allen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Cell surface expression and function of an HLA class II molecule with class I domain configuration.

Authors:  R R Olson; J J Reuter; K Scalf
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

8.  The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex.

Authors:  M Bellio; Y C Lone; O de la Calle-Martin; B Malissen; J P Abastado; P Kourilsky
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

9.  Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal.

Authors:  S Ceman; S Wu; T S Jardetzky; A J Sant
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

10.  Recognition of multiple peptide cores by a single T cell receptor.

Authors:  N K Nanda; K K Arzoo; H M Geysen; A Sette; E E Sercarz
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.